4.5 Article

The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

A dose response randomised controlled trial of docosahexaenoic acid (DHA) in preterm infants

C. T. Collins et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2015)

Article Nutrition & Dietetics

Impact of the omega-3 to omega-6 Polyunsaturated Fatty Acid Ratio on Cytokine Release in Human Alveolar Cells

Paolo Cotogni et al.

JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2011)

Article Pediatrics

The management of evolving bronchopulmonary dysplasia

Sven M. Schulzke et al.

PAEDIATRIC RESPIRATORY REVIEWS (2010)

Review Respiratory System

Pathogenesis of Bronchopulmonary Dysplasia

Don Hayes et al.

RESPIRATION (2010)

Review Biochemistry & Molecular Biology

Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale

Philip C. Calder

BIOCHIMIE (2009)

Article Medicine, General & Internal

Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid A Randomized Controlled Trial

Maria Makrides et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Pediatrics

Long-term outcomes of bronchopulmonary dysplasia

Lex W. Doyle et al.

SEMINARS IN FETAL & NEONATAL MEDICINE (2009)

Review Immunology

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

Charles N. Serhan et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Article Obstetrics & Gynecology

Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses

PG Blanco et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)